Professor John Lim, founding Executive Director of the Duke-NUS Centre of Regulatory Excellence (CoRE) and Policy Core Lead of the SingHealth Duke-NUS Global Health Institute, was recently elected to the US Pharmacopeia Board of Trustees.

The US Pharmacopeia is an independent, scientific, non-profit organisation that publishes standards for drugs, food ingredients, and dietary supplements in the US and internationally. Members of its Board of Trustees, elected by the membership of the USP Convention during the Membership Governance Meeting held every five years, advise on strategy, provide fiduciary oversight, and help to safeguard USP’s reputation and standards.

On 9 April, the 2025 edition of Research Day was held at the Ngee Ann Kongsi Auditorium, where the Classes of 2025 and 2026 gathered to present their research projects. Opening with remarks by Professor Pierce Chow, Co-Chair of the Research and Scholarship Committee, and Dean Thomas Coffman, the event showcased a variety of research projects, presented in poster and oral presentation formats. Attendees also sat in on a Q&A session with students who performed their research at the Duke Durham campus, and, for the first time, participated in a media training session where they practised talking to the press.

Professor Paul Yen, from Duke-NUS’ Cardiovascular and Metabolic Disorders Programme, was recently awarded the John Stanbury Thyroid Pathophysiology Medal from the American Thyroid Association (ATA). The award, one of the ATA’s highest honours, recognises individuals whose research significantly advanced the understanding of thyroid physiology or the pathophysiology of thyroid disease, and was awarded to Prof Yen for his contributions to thyroid hormone research and its therapeutic potential in treating metabolic diseases.

The ATA is a leading global authority in advancing thyroid health through science, clinical care, education and advocacy, with more than 1700 members across 70 countries.